Anti-TBE Virus ELISA 2.0 (IgG) After EUROIMMUN received the required certificate for its quality management system in accordance with the new European Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) in May of this year, the first newly…
Der Beitrag First newly developed ELISA of risk class B declared IVDR-compliant erschien zuerst auf EUROIMMUNBlog.
Dried blood spots (DBS) collected from the fingertip yield reliable results in analysis of anti-SARS-CoV-2 antibodies, even after prolonged storage of DBS eluates for 6 to 8 hours. This was demonstrated in a recently published study from MVZ Labor Krone…
Der Beitrag Dried blood spots provide easy, reliable antibody testing erschien zuerst auf EUROIMMUNBlog.
A recent study has demonstrated substantial differences in SARS-CoV-2 immunity after Omicron infection in triple-COVID-19-vaccinated and antigen-naïve individuals, which may influence cross-protection against future variants. The study was performed as part of a collaboration between the Hannover Medical School, Germany…
Der Beitrag Omicron-induced T- and B-cell immunity in vaccinated and naïve individuals erschien zuerst auf EUROIMMUNBlog.
Claus Ruhe Madsen, Minister of Economic Affairs, Transport, Employment, Technology and Tourism of the German state of Schleswig-Holstein, together with Dr. Jürgen Walkenhorst and Dr. Georg Eschenburg of the association “Life Science Nord”, visited EUROIMMUN’s headquarters in Lübeck last week…
Der Beitrag Schleswig-Holstein’s Minister of Economic Affairs visits EUROIMMUN erschien zuerst auf EUROIMMUNBlog.
In our latest video, Mr Mende tells us how autoantibody determination completely changed his prognosis. For the past six years, Mr Mende has suffered from necrotising myositis, an autoimmune disease that mainly affects the connective tissue and muscles. Today he…
Der Beitrag A life-saving diagnosis thanks to comprehensive antibody testing – a motivating success story erschien zuerst auf EUROIMMUNBlog.
Availability of EUROIMMUN products in the EU secured On May 10, 2023, EUROIMMUN received the certificate for its quality management system according to the new European Regulation on in vitro diagnostic medical devices (EU) 2017/746 (IVDR) from TÜV Rheinland LGA…
Der Beitrag EUROIMMUN receives IVDR certificate erschien zuerst auf EUROIMMUNBlog.
The UNIQO 160 embodies the next generation of fully automated systems for indirect immunofluorescence diagnostics. What is behind it? After the fully automated processing of the indirect immunofluorescence tests (IIFT), the system automatically covers the incubated slides with mounting medium…
Der Beitrag UNIQO 160 – from primary sample to final result erschien zuerst auf EUROIMMUNBlog.
As the capstone in a multi-year transformation process, on May 9th, our parent company unveiled its new name and brand – Revvity. For more than five years, EUROIMMUN has been part of PerkinElmer, Inc., which completed a divestiture of its…
Der Beitrag Our parent company reveals its new name and brand erschien zuerst auf EUROIMMUNBlog.
The cytoskeleton protein septin-3 has been identified as a novel target antigen of autoantibodies in patients with paraneoplastic cerebellar ataxia. The new biomarker was discovered in a collaborative study between scientists at EUROIMMUN, the University of Heidelberg and further clinics…
Der Beitrag Novel autoantibody against septin-3 discovered in neurological disease erschien zuerst auf EUROIMMUNBlog.
Deep neural networks incorporating segmentation provide highly accurate classification of immunofluorescence patterns on the tissue substrates esophagus and salt-split skin for detection of autoimmune bullous dermatoses (AIBD). A recently published study in collaboration with researchers at the Department of Dermatology…
Der Beitrag Computer-aided classification of IIF patterns in autoimmune dermatoses erschien zuerst auf EUROIMMUNBlog.
Cart is empty